Focal nodular hyperplasia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| Line 2: | Line 2: | ||
{{Focal nodular hyperplasia}} | {{Focal nodular hyperplasia}} | ||
{{CMG}}; {{AE | {{CMG}}; {{AE}} | ||
==[[Focal nodular hyperplasia overview|Overview]]== | ==[[Focal nodular hyperplasia overview|Overview]]== | ||
Revision as of 14:12, 15 July 2016
Template:Focal nodular hyperplasia
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Focal nodular hyperplasia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram |X Ray | CT | MRI | | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies